Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
89,063,766
-
Shares change
-
+4,008,302
-
Total reported value, excl. options
-
$1,077,729,997
-
Value change
-
+$45,482,106
-
Put/Call ratio
-
73%
-
Number of buys
-
103
-
Number of sells
-
-88
-
Price
-
$12.10
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q4 2019
238 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q4 2019.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89,063,766 shares
of 105,863,294 outstanding shares and own 84% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15,920,086 shares), VANGUARD GROUP INC (10,948,746 shares), FEDERATED HERMES, INC. (8,874,400 shares), INGALLS & SNYDER LLC (8,014,351 shares), RENAISSANCE TECHNOLOGIES LLC (7,768,214 shares), STATE STREET CORP (3,027,521 shares), DIMENSIONAL FUND ADVISORS LP (2,530,017 shares), Invesco Ltd. (1,950,076 shares), LSV ASSET MANAGEMENT (1,718,424 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,432,606 shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.